Surbhi created a new blog entry
on July 28 2026 at 05:39 PM public
Sodium Glucose Cotransporter 2 Inhibitor Market: How Are Cardiorenal Benefits Expanding SGLT2i Indications Far Beyond Type 2 Diabetes?
Sodium-glucose cotransporter 2 inhibitors — the oral agents that block renal proximal tubular glucose reabsorption, producing glucosuria, osmotic diuresis, and natriuresis — have undergone one...